Narrow search
Showing 1 - 10 of 204
Cover Image
Does participation in clinical trials influence the costs of future management of patients?
Hvenegaard, Anne; Juhl, Henrik Hauschildt; Habicht, … - In: The European journal of health economics : HEPAC ; … 13 (2012) 5, pp. 569-574
Persistent link: https://www.econbiz.de/10009657330
Cover Image
Drug overprescription in nursing homes: an empirical evaluation of administrative data
Stroka, Magdalena A. - In: The European journal of health economics : HEPAC ; … 17 (2016) 3, pp. 257-267
Persistent link: https://www.econbiz.de/10011654600
Cover Image
Patient preferences : a Trojan horse for evidence-based medicine?
Gandjour, Afschin - In: The European journal of health economics : HEPAC ; … 19 (2018) 1, pp. 167-172
Persistent link: https://www.econbiz.de/10011946179
Cover Image
Pricing and reimbursement of pharmaceuticals in Italy
Folino-Gallo, Pietro; Montilla, Simona; Bruzzone, Mario; … - In: The European journal of health economics : HEPAC ; … 9 (2008) 3, pp. 305-310
Persistent link: https://www.econbiz.de/10003731981
Cover Image
Price regulation and generic competition in the pharmaceutical market
Dalen, Dag Morten; Strøm, Steinar; Haabeth, Tonje - In: The European journal of health economics : HEPAC ; … 7 (2006) 3, pp. 208-214
Persistent link: https://www.econbiz.de/10003378742
Cover Image
Future challenges for health economics and health technology assessment of biological drugs
Gulácsi, László - In: The European journal of health economics : HEPAC ; … 11 (2010) 3, pp. 235-238
Persistent link: https://www.econbiz.de/10003978853
Cover Image
The impact of reference pricing on switching behaviour and healthcare utilisation : the case of statins in Germany
Stargardt, Tom - In: The European journal of health economics : HEPAC ; … 11 (2010) 3, pp. 267-277
Persistent link: https://www.econbiz.de/10003978858
Cover Image
Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan : hospital-level prescription of thiazolidinediones for diabetes
Tsai, Yi-wen; Wen, Yu-wen; Huang, Weng-foung; Kuo, Ken N.; … - In: The European journal of health economics : HEPAC ; … 11 (2010) 3, pp. 279-290
Persistent link: https://www.econbiz.de/10003978860
Cover Image
Saving lives, money and resources : drug and CABG/PCI use after myocardial infarction in a Swedish record-linkage study
Wilhelmsen, Lars; Welin, Lennart; Odén, Anders; … - In: The European journal of health economics : HEPAC ; … 11 (2010) 2, pp. 177-184
Persistent link: https://www.econbiz.de/10003948438
Cover Image
Methods for determining cost-benefit ratios for pharmaceuticals in Germany
Schulenburg, Johann-Matthias von der; Vauth, Christoph; … - In: The European journal of health economics : HEPAC ; … 8 (2007), pp. 5-31
Persistent link: https://www.econbiz.de/10003546582